| Application no. and date | 19732494.0 (espacenet) (Federated) (European Patent Register), 20190522 | | Patent/reg. no. and date | DK/EP 3796912, 20230215 | | Publication date | 20210331 | | Priority no. and date | US 201862675639 P, 20180523 | | EP pub. no. and date |
EP 3796912 20210331 | | Effective date | | | Applicant/owner | Celgene Corporation, 86 Morris Avenue
Summit, NJ 07901, US | | Applicant ref. no. | P82341DK01 | | Inventor | PIERCE, Daniel, W., 1500 Owens Street, Suite 500
San Francisco, CA 94158, US,
WONG, Lilly, L., 10300 Campus Point Drive, Suite 100
San Diego, CA 92121, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/496 (2006.01) , A61K 31/497 (2006.01) , A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) , A61P 35/02 (2006.01) , C07K 16/28 (2006.01) | | Title | ANTIPROLIFERATIVE FORBINDELSER OG BISPECIFIKT ANTISTOF MOD BCMA OG CD3 TIL KOMBINERET ANVENDELSE | | Int. application no. | US2019033505 | | Int. publication no. | WO2019226761 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
